At the moment, most cancer treatments are combinations of chemotherapeutic agents and/or radiotherapy, and it is expected that new EGFR‐targeted agents will achieve their greatest efficacy in combination with traditional cytotoxic agents and/or radiotherapy. Here, EGFR is linked to cancer.